巴西东北部一个州卵巢癌净生存趋势（1996-2017）。

IF 2.4 3区医学 Q3 ONCOLOGY

Cancer Epidemiology Pub Date : 2025-02-01 DOI:10.1016/j.canep.2024.102720

Brenda Evelin Barreto da Silva , Pamela Minicozzi , Veronica Di Carlo , Naomi Ssenyonga , Fatima Khan Baloch , Melissa Matz , Michel P. Coleman , Claudia Allemani , Carlos Anselmo Lima

{"title":"巴西东北部一个州卵巢癌净生存趋势（1996-2017）。","authors":"Brenda Evelin Barreto da Silva , Pamela Minicozzi , Veronica Di Carlo , Naomi Ssenyonga , Fatima Khan Baloch , Melissa Matz , Michel P. Coleman , Claudia Allemani , Carlos Anselmo Lima","doi":"10.1016/j.canep.2024.102720","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Ovarian cancer survival in low- and middle-income countries is lower than in high-income countries, due to disparities in healthcare access and socioeconomic factors. This study aimed to describe trends in ovarian cancer survival in Sergipe, Northeast Brazil, by histological group.</div></div><div><h3>Methods</h3><div>We analysed data on 948 women aged 15–99 years diagnosed with a cancer of the ovary between 1996 and 2017, in Sergipe, Brazil. One- and five-year net survival were estimated by histological group and calendar periods of diagnosis (1996–1999, 2000–2004, 2005–2009, 2010–2014, 2015–2017) using the Pohar-Perme estimator. Survival estimates were age-standardised using International Cancer Survival Standard weights.</div></div><div><h3>Results</h3><div>Between 1996 and 2017, one-year and five-year net survival for ovarian cancer were 63.4 % and 37.4 %, respectively. Five-year net survival trends increased from 30.9 % (2000–2004) to 46.8 % (2015–2017). Epithelial type I tumours comprised roughly a quarter of cases, while type II tumours constituted over half. Both types exhibited similar one-year survival, ranging from 67 % to 68.5 % during 1996–2017. However, five-year net survival for type II tumours was remarkably lower at 32.5 %, compared to 52 % for type I tumours.</div></div><div><h3>Conclusion</h3><div>Despite a minor improvement in five-year net survival over the 22 years, survival for women with ovarian cancer remains unfavourable, particularly for those diagnosed with Type II epithelial tumours, which have remarkably lower five-year survival than Type I.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"94 ","pages":"Article 102720"},"PeriodicalIF":2.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trends in ovarian cancer net survival in a northeastern Brazilian state (1996–2017)\",\"authors\":\"Brenda Evelin Barreto da Silva , Pamela Minicozzi , Veronica Di Carlo , Naomi Ssenyonga , Fatima Khan Baloch , Melissa Matz , Michel P. Coleman , Claudia Allemani , Carlos Anselmo Lima\",\"doi\":\"10.1016/j.canep.2024.102720\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Ovarian cancer survival in low- and middle-income countries is lower than in high-income countries, due to disparities in healthcare access and socioeconomic factors. This study aimed to describe trends in ovarian cancer survival in Sergipe, Northeast Brazil, by histological group.</div></div><div><h3>Methods</h3><div>We analysed data on 948 women aged 15–99 years diagnosed with a cancer of the ovary between 1996 and 2017, in Sergipe, Brazil. One- and five-year net survival were estimated by histological group and calendar periods of diagnosis (1996–1999, 2000–2004, 2005–2009, 2010–2014, 2015–2017) using the Pohar-Perme estimator. Survival estimates were age-standardised using International Cancer Survival Standard weights.</div></div><div><h3>Results</h3><div>Between 1996 and 2017, one-year and five-year net survival for ovarian cancer were 63.4 % and 37.4 %, respectively. Five-year net survival trends increased from 30.9 % (2000–2004) to 46.8 % (2015–2017). Epithelial type I tumours comprised roughly a quarter of cases, while type II tumours constituted over half. Both types exhibited similar one-year survival, ranging from 67 % to 68.5 % during 1996–2017. However, five-year net survival for type II tumours was remarkably lower at 32.5 %, compared to 52 % for type I tumours.</div></div><div><h3>Conclusion</h3><div>Despite a minor improvement in five-year net survival over the 22 years, survival for women with ovarian cancer remains unfavourable, particularly for those diagnosed with Type II epithelial tumours, which have remarkably lower five-year survival than Type I.</div></div>\",\"PeriodicalId\":56322,\"journal\":{\"name\":\"Cancer Epidemiology\",\"volume\":\"94 \",\"pages\":\"Article 102720\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1877782124001991\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877782124001991","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

背景：由于医疗保健可及性和社会经济因素方面的差异，低收入和中等收入国家的卵巢癌生存率低于高收入国家。本研究旨在通过组织学分组描述巴西东北部Sergipe地区卵巢癌生存率的趋势。方法：我们分析了1996年至2017年间巴西Sergipe 948名15-99岁被诊断患有卵巢癌的女性的数据。使用Pohar-Perme估计器，按组织学组和日历诊断期（1996-1999、2000-2004、2005-2009、2010-2014、2015-2017）估计1年和5年净生存率。生存估计使用国际癌症生存标准权重进行年龄标准化。结果：1996年至2017年，卵巢癌的1年和5年净生存率分别为63.4 %和37.4 %。5年净生存趋势从30.9% %（2000-2004年）增加到46.8% %（2015-2017年）。上皮I型肿瘤约占病例的四分之一，而II型肿瘤占一半以上。1996-2017年，两种类型的一年生存率相似，从67 %到68.5 %不等。然而，II型肿瘤的5年净生存率为32.5% %，而I型肿瘤的5年净生存率为52% %。结论：尽管22年的5年净生存率略有改善，但卵巢癌妇女的生存率仍然不利，特别是那些被诊断为II型上皮肿瘤的妇女，其5年生存率明显低于I型。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Trends in ovarian cancer net survival in a northeastern Brazilian state (1996–2017)

Background

Ovarian cancer survival in low- and middle-income countries is lower than in high-income countries, due to disparities in healthcare access and socioeconomic factors. This study aimed to describe trends in ovarian cancer survival in Sergipe, Northeast Brazil, by histological group.

Methods

We analysed data on 948 women aged 15–99 years diagnosed with a cancer of the ovary between 1996 and 2017, in Sergipe, Brazil. One- and five-year net survival were estimated by histological group and calendar periods of diagnosis (1996–1999, 2000–2004, 2005–2009, 2010–2014, 2015–2017) using the Pohar-Perme estimator. Survival estimates were age-standardised using International Cancer Survival Standard weights.

Results

Between 1996 and 2017, one-year and five-year net survival for ovarian cancer were 63.4 % and 37.4 %, respectively. Five-year net survival trends increased from 30.9 % (2000–2004) to 46.8 % (2015–2017). Epithelial type I tumours comprised roughly a quarter of cases, while type II tumours constituted over half. Both types exhibited similar one-year survival, ranging from 67 % to 68.5 % during 1996–2017. However, five-year net survival for type II tumours was remarkably lower at 32.5 %, compared to 52 % for type I tumours.

Conclusion

Despite a minor improvement in five-year net survival over the 22 years, survival for women with ovarian cancer remains unfavourable, particularly for those diagnosed with Type II epithelial tumours, which have remarkably lower five-year survival than Type I.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Epidemiology 医学-肿瘤学

CiteScore

4.50

自引率

3.80%

发文量

200

审稿时长

39 days

期刊介绍： Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: • Descriptive epidemiology • Studies of risk factors for disease initiation, development and prognosis • Screening and early detection • Prevention and control • Methodological issues The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.